In another case, the patient with colorectal cancer developed methylprednisolone-induced thrombocytopenia after the oxaliplatin-induced thrombocytopenia, attributable to the oxaliplatin immune-induced syndrome owing to anti-GPIIbIIIa and anti-CD36 antibodies (34). Here, CD36 is linked to colorectal cancer.